TY - JOUR
T1 - Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
AU - Sierra, J. Rafael
AU - Cepero, Virna
AU - Giordano, Silvia
PY - 2010/4/12
Y1 - 2010/4/12
N2 - In recent years, tyrosine kinases (TKs) have been recognized as central players and regulators of cancer cell proliferation, apoptosis, and angiogenesis, and are therefore considered suitable potential targets for anti-cancer therapies. Several strategies for targeting TKs have been developed, the most successful being monoclonal antibodies and small molecule tyrosine kinase inhibitors. However, increasing evidence of acquired resistance to these drugs has been documented, and extensive preclinical studies are ongoing to try to understand the molecular mechanisms by which cancer cells are able to bypass their inhibitory activity. This review intends to present the most recently identified molecular mechanisms that mediate acquired resistance to tyrosine kinase inhibitors, identified through the use of in vitro models or the analysis of patient samples. The knowledge obtained from these studies will help to design better therapies that prevent and overcome resistance to treatment in cancer patients.
AB - In recent years, tyrosine kinases (TKs) have been recognized as central players and regulators of cancer cell proliferation, apoptosis, and angiogenesis, and are therefore considered suitable potential targets for anti-cancer therapies. Several strategies for targeting TKs have been developed, the most successful being monoclonal antibodies and small molecule tyrosine kinase inhibitors. However, increasing evidence of acquired resistance to these drugs has been documented, and extensive preclinical studies are ongoing to try to understand the molecular mechanisms by which cancer cells are able to bypass their inhibitory activity. This review intends to present the most recently identified molecular mechanisms that mediate acquired resistance to tyrosine kinase inhibitors, identified through the use of in vitro models or the analysis of patient samples. The knowledge obtained from these studies will help to design better therapies that prevent and overcome resistance to treatment in cancer patients.
UR - http://www.scopus.com/inward/record.url?scp=77950678272&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950678272&partnerID=8YFLogxK
U2 - 10.1186/1476-4598-9-75
DO - 10.1186/1476-4598-9-75
M3 - Article
C2 - 20385023
AN - SCOPUS:77950678272
VL - 9
JO - Molecular Cancer
JF - Molecular Cancer
SN - 1476-4598
M1 - 75
ER -